Greenwood Capital Associates LLC Sells 827 Shares of Semler Scientific, Inc. (NASDAQ:SMLR)

Greenwood Capital Associates LLC reduced its position in Semler Scientific, Inc. (NASDAQ:SMLR) by 4.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,978 shares of the company’s stock after selling 827 shares during the period. Greenwood Capital Associates LLC owned 0.29% of Semler Scientific worth $470,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of SMLR. Janney Montgomery Scott LLC purchased a new position in shares of Semler Scientific during the first quarter valued at approximately $700,000. LSV Asset Management lifted its position in Semler Scientific by 58.0% during the first quarter. LSV Asset Management now owns 252,887 shares of the company’s stock valued at $7,387,000 after acquiring an additional 92,851 shares during the last quarter. Horizon Investment Services LLC lifted its holdings in shares of Semler Scientific by 35.8% during the 1st quarter. Horizon Investment Services LLC now owns 8,352 shares of the company’s stock valued at $244,000 after purchasing an additional 2,203 shares during the last quarter. Acadian Asset Management LLC increased its holdings in shares of Semler Scientific by 68.2% during the first quarter. Acadian Asset Management LLC now owns 165,876 shares of the company’s stock valued at $4,843,000 after acquiring an additional 67,282 shares in the last quarter. Finally, Truvestments Capital LLC purchased a new position in shares of Semler Scientific in the first quarter worth $263,000. 49.37% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, CEO Douglas Murphy-Chutorian sold 10,000 shares of Semler Scientific stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $28.35, for a total transaction of $283,500.00. Following the transaction, the chief executive officer now owns 60,220 shares in the company, valued at approximately $1,707,237. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 30.20% of the company’s stock.

Semler Scientific Price Performance

NASDAQ SMLR opened at $39.00 on Wednesday. The stock’s fifty day moving average price is $26.12 and its 200 day moving average price is $28.73. Semler Scientific, Inc. has a 1 year low of $20.88 and a 1 year high of $53.38. The company has a market cap of $272.61 million, a price-to-earnings ratio of 19.12 and a beta of 0.92.

Semler Scientific (NASDAQ:SMLR) last issued its earnings results on Monday, November 4th. The company reported $0.72 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.35. The firm had revenue of $13.51 million for the quarter. Semler Scientific had a return on equity of 21.17% and a net margin of 25.62%.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.